Stop the immune system from attacking healthy beta cells, preventing T1D from ever occurring.
Spur beta cell growth safely and protect them, so people with T1D can live without life-long external insulin.
Develop treatments that can halt, slow or reverse the events that drive T1D.
Developing a global universal T1D risk screening strategy to identify high-risk individuals, reduce DKA at diagnosis, and speed up the development of disease-modifying therapies by accelerating clinical trials.
Investing in research and clinical trials aimed at developing and delivering life-changing therapies that insert healthy, insulin-producing beta cells into people with T1D, with minimal or no immunosuppression, keeping them healthy for longer.
People with T1D must have tools, therapies, and interventions to keep them healthy so that when cures come to fruition, they are healthy enough to take advantage of them.